News | Radiation Therapy | March 27, 2017

Virtual Environment Education Reduces Pre-Radiotherapy Anxiety in Prostate Cancer Patients

Survey study shows using virtual reality technology helps answer patient questions about radiotherapy procedures

VERT, virtual environment radiotherapy, radiation therapy, patient anxiety, Thomas Jefferson University study

March 27, 2017 — Radiation therapists and physicians know that education can reduce anxiety before radiation treatment but lack a standardized tool. In an effort to solve this problem, a multidisciplinary team from Jefferson College of Health Professions and Sidney Kimmel Cancer Center at Thomas Jefferson University conducted a pilot study to see if a virtual environment education program could reduce some of the anxiety their patients face. They published their results in the Journal of Radiation Oncology.

“So many aspects of cancer care can produce anxiety for our patients, which can negatively impact their health and wellbeing,” said Matthew Marquess, MBA, RT(T), co-first author and program director of radiation therapy in the Radiologic Sciences Department of Jefferson College of Health Professions. “Our pilot study showed that by using a simulated environment to teach our patients about their upcoming radiation therapy treatments, we can significantly increase their understanding of the treatment and reduce their anxiety.”

To evaluate the program’s efficacy, 22 patients with prostate cancer completed a 16-question survey to assess their anxiety and comprehension. The survey measured patients’ anxiety levels associated with various aspects of care including being alone in the treatment room, treatment precision, claustrophobia, effects of daily X-rays, pain and others. Patients then received personalized education with co-first authors Marquess and Shirley Johnston, MS, CMD, RT(T)(R), director of the Medical Dosimetry program in Jefferson College of Health Professions. The team used Virtual Environment Radiotherapy (VERT) software, which is modeled after a flight simulator for radiation therapy, including life-size visualizations and three-dimensional views. After the education session, patients repeated the survey.

“Our pre- and post- survey results showed a significant decrease in anxiety and increase in comprehension,” said Robert Den, M.D., associate professor of radiation oncology in Sidney Kimmel Cancer Center. “Even better, our patients’ and their families’ comments were unanimously positive with themes of improved confidence, relief and satisfaction.”

Co-authors include Shirley Pinegar Johnston, MS, CMD, RT(T)(R); Noelle Williams, M.D.; Carolyn Giordano, Ph.D.; Benjamin Leiby, Ph.D.; Mark Hurwitz, M.D.; and Adam Dicker, M.D., Ph.D.

For more information: www.springer.com

Related Content

New Study Evaluates Head CT Examinations and Patient Complexity
News | Neuro Imaging | May 17, 2019
Computed tomography (CT) of the head uses special X-ray equipment to help assess head injuries, dizziness and other...
New Phase 2B Trial Exploring Target-Specific Myocardial Ischemia Imaging Agent
News | Radiopharmaceuticals and Tracers | May 17, 2019
Biopharmaceutical company CellPoint plans to begin patient recruitment for its Phase 2b cardiovascular imaging study in...
Managing Architectural Distortion on Mammography Based on MR Enhancement
News | Mammography | May 15, 2019
High negative predictive values (NPV) in mammography architectural distortion (AD) without ultrasonographic (US)...
New Method Improves Ability to Measure and Maximize Radiation Therapy Dose
News | Radiation Therapy | May 14, 2019
Delivering just the right dose of radiation for cancer patients is a delicate balance in their treatment regime....
Icon Launches New Clinical Trial Patient Engagement Platform
Technology | Patient Engagement | May 14, 2019
Icon plc announced the release of its web-based clinical trial patient engagement platform, to provide patients with...
Blue Earth Diagnostics Expands Access to Axumin in Europe
News | Radiopharmaceuticals and Tracers | May 13, 2019
Blue Earth Diagnostics announced expanded access to the Axumin (fluciclovine (18F)) imaging agent in Europe. The first...
Sponsored Content | Videos | Radiation Oncology | May 13, 2019
At ASTRO 2018, Accuray showcased new patient-fi
Radiotherapy After Chemo May Improve Survival in Advanced Hodgkin's Lymphoma Patients
News | Radiation Therapy | May 10, 2019
Patients with advanced Hodgkin's lymphoma who have large tumors at the time of diagnosis may benefit from radiotherapy...
IBA Partnering to Develop Advanced Digital Proton Therapy Technologies in Belgium
News | Proton Therapy | May 10, 2019
IBA (Ion Beam Applications SA) announced a research agreement with Skandionkliniken, Université Catholique de Louvain...
A CyberHeart cardiac ablation radiotherapy treatment plan showing where the radiation beam will ablate for a noninvasive pulmonary vein isolation procedure. Varian acquires, buys, purchases Cyberheart.

A CyberHeart cardiac ablation radiotherapy treatment plan showing where the radiation beams will ablate for a noninvasive pulmonary vein isolation procedure to treat an arrhythmia.

Feature | Radiation Therapy | May 10, 2019
May 10, 2019 — Radiation oncology vendor Varian announced it acquired the start-up company CyberHeart, which has deve